Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0508
+0.0008 (1.64%)
Aug 15, 2025, 11:34 AM EDT
Oncotelic Therapeutics Employees
Oncotelic Therapeutics had 26 employees as of December 31, 2024. The number of employees increased by 4 or 18.18% compared to the previous year.
Employees
26
Change (1Y)
4
Growth (1Y)
18.18%
Revenue / Employee
n/a
Profits / Employee
-$151,011
Market Cap
22.10M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
American Oncology Network | 1,914 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
Oncotelic Therapeutics News
- 12 days ago - OTCQB Venture Virtual Investor Conference Agenda Announced for August 7th - GlobeNewsWire
- 4 weeks ago - SAPU Bioscience Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients - GlobeNewsWire
- 4 weeks ago - Oncotelic Therapeutics Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients - GlobeNewsWire
- 7 weeks ago - Oncotelic Therapeutics Announces Publication of Landmark Study on TGFB2 Gene Methylation as a Positive Prognostic Marker in Pancreatic Cancer - GlobeNewsWire
- 4 months ago - Oncotelic CEO Vuong Trieu to Present Innovative "Deciparticles" Platform at IDDST-Europe 2025 Conference in Stockholm - GlobeNewsWire
- 4 months ago - Oncotelic Therapeutics Reports FY 2024 Highlights and FY 2024 Earnings Compared to FY 2023 - GlobeNewsWire
- 4 months ago - Oncotelic Therapeutics Publishes New Research Demonstrating Positive Prognostic Impact of Methylated TGFB2 and MGMT in Adult Glioblastoma Patients, Introduces Interactive PDAOAI - GlobeNewsWire
- 5 months ago - Oncotelic Therapeutics Announces Successful Completion of Phase 1 Trial of OT-101 and IL-2, Highlights Findings at SWCR 2025 Conference - GlobeNewsWire